Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Marvin J. Grubman"'
Autor:
Luizinho Caron, Mario C.S. Brum, Mauro P. Moraes, William T. Golde, Clarice Weis Arns, Marvin J. Grubman
Publikováno v:
Pesquisa Veterinária Brasileira, Vol 25, Iss 3, Pp 150-158 (2005)
Foot-and-mouth disease (FMD) is one of the most feared diseases of livestock worldwide. Vaccination has been a very effective weapon in controlling the disease, however a number of concerns with the current vaccine including the inability of approved
Externí odkaz:
https://doaj.org/article/3a3c27385c604766b60f4ac386b8e153
Publikováno v:
BioTechniques, Vol 31, Iss 5, Pp 1050-1056 (2001)
We have engineered a new vector that makes use of direct ligation for the generation of replication-defective recombinant adenovirus constructs. In the pAd5-Blue vector, unique yet common restriction endonuclease sites exist, that allow cloning in a
Externí odkaz:
https://doaj.org/article/ff436a3fbc354ee1aa98664115a00e82
Autor:
Anna Kloc, Teresa de los Santos, Elizabeth Rieder, Alexander L. Greninger, Gisselle N. Medina, Fayna Diaz-San Segundo, Marvin J. Grubman, Joseph L. DeRisi, Giselle M. Knudsen
Publikováno v:
Virology. 505:12-22
The foot-and-mouth disease virus (FMDV) leader protease (Lpro) inhibits host translation and transcription affecting the expression of several factors involved in innate immunity. In this study, we have identified the host transcription factor ADNP (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dec751122abb3d82eccda327f5bca73a
https://doi.org/10.1016/j.virol.2017.02.010
https://doi.org/10.1016/j.virol.2017.02.010
Autor:
Ignacio Fernandez-Sainz, Teresa de los Santos, Marvin J. Grubman, Gisselle N. Medina, Marla Koster, Elizabeth Ramirez-Medina
Publikováno v:
Virology. 502:123-132
A human adenovirus (Ad5) vectored foot-and-mouth disease virus (FMDV) O1-Manisa subunit vaccine (Ad5-O1Man) was engineered to deliver FMDV O1-Manisa capsid and capsid-processing proteins. Swine inoculated with Ad5-O1Man developed an FMDV-specific hum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7c0f39e51e24bbcc2ac9897fe619a2f
https://doi.org/10.1016/j.virol.2016.12.021
https://doi.org/10.1016/j.virol.2016.12.021
Publikováno v:
Veterinary Research Communications. 41:15-22
Background It has been recognized that the expression of type I interferon (IFN alpha/beta) may be suppressed during infection with porcine reproductive, respiratory syndrome virus (PRRSV). This causes profound negative effects on both the innate and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27d651c857f693b048e99a0235755caf
https://doi.org/10.1007/s11259-016-9665-6
https://doi.org/10.1007/s11259-016-9665-6
Autor:
Barbara J. Kamicker, Gregory A. Mayr, David A. Brake, Mauro P. Moraes, Laszlo Zsak, Damodar Ettyreddy, Christopher Schutta, Douglas E. Brough, Marvin J. Grubman, Bryan T. Butman, Melia Pisano, John G. Neilan, José Barrera
Publikováno v:
Vaccine. 34:3214-3220
The safety and efficacy of an experimental, replication-deficient, human adenovirus-vectored foot-and-mouth disease virus (FMDV) serotype A24 Cruzeiro capsid-based subunit vaccine (AdtA24) was examined in eight independent cattle studies. AdtA24 non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0f2f1b27d3239a25e83b4fe4903c486
https://doi.org/10.1016/j.vaccine.2015.12.018
https://doi.org/10.1016/j.vaccine.2015.12.018
Autor:
Marvin J. Grubman, Elizabeth Ramirez-Medina, Diego F. Sturza, Fayna Diaz-San Segundo, Gisselle N. Medina, Teresa de los Santos, Nestor Montiel
Publikováno v:
Clinical and Vaccine Immunology. 23:125-136
Novel vaccination approaches against foot-and-mouth disease (FMD) include the use of replication-defective human adenovirus type 5 (Ad5) vectors that contain the capsid-encoding regions of FMD virus (FMDV). Ad5 containing serotype A24 capsid sequence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4cd794beaabf6f5bf76aff91be583ff
https://doi.org/10.1128/cvi.00426-15
https://doi.org/10.1128/cvi.00426-15
Autor:
Douglas E. Brough, Marvin J. Grubman, John G. Neilan, Bryan T. Butman, José Barrera, Barbara J. Kamicker, David A. Brake, Melia Pisano, Damodar Ettyreddy, Christopher Schutta, Femi Olutunmbi, Timothy J. Miller
Publikováno v:
Vaccine. 36(8)
A foot-and-mouth disease (FMD) recombinant subunit vaccine formulated with a lipid/polymer adjuvant was evaluated in two vaccine efficacy challenge studies in steers. The vaccine active ingredient is a replication-deficient human adenovirus serotype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b90b7b1b4246a4fd6e5ac3cb2120391
https://pubmed.ncbi.nlm.nih.gov/29358056
https://pubmed.ncbi.nlm.nih.gov/29358056
Autor:
T. de los Santos, Marla Koster, M. Hosamani, Suresh H. Basagoudanavar, B.P. Sreenivasa, Paramasivam Saravanan, Marvin J. Grubman, V.C. Dhanya, Steven J. Pauszek, Ramamurthy Venkataramanan, Luis L. Rodriguez, Jajati K. Mohapatra, R. P. Tamil Selvan
Publikováno v:
Veterinary microbiology. 203
Recombinant adenovirus-5 vectored foot-and-mouth disease constructs (Ad5- FMD) were made for three Indian vaccine virus serotypes O, A and Asia 1. Constructs co-expressing foot-and- mouth disease virus (FMDV) capsid and viral 3C protease sequences, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::346fa924af82fe38916fb3fa4f0587f6
https://pubmed.ncbi.nlm.nih.gov/28619144
https://pubmed.ncbi.nlm.nih.gov/28619144
Publikováno v:
Foot and Mouth Disease Virus: Current Research and Emerging Trends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dea2d3a59500aa702d7f4d8818b465a
https://doi.org/10.21775/9781910190517.14
https://doi.org/10.21775/9781910190517.14
